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Background: The purpose of this study was to compare the refractive outcomes of small incision lenticule
extraction (SMILE) in high-myopic patients with those of mild- to moderate-myopic patients.
Methods: This study included 183 eyes of 92 myopic patients treated with SMILE using a VisuMax 500-kHz femtosecond
laser. Treated eyes were divided into two groups, according to the preoperative spherical equivalent (SE): mild to
moderate myopia (A group, <−6.0 D) and high myopia (B group, ≥ − 6.0 D). Follow-up visits were at 1 day, 1 week,
and 1, 3, 6, and 12 months. The outcome measures included uncorrected distance visual acuity (UDVA), best-corrected
distance visual acuity (BDVA), postoperative SE, efficacy index, safety index, and predictability.
Results: Preoperative SE was −5.05 ± 0.71 D in the A group and −7.67 ± 1.01 D in the B group. No differences were
observed between −0.13 ± 0.38 D in the A group and −0.24 ± 0.35 D in the B group 12 months postoperatively
(p = 0.18). At 12 months postoperatively, 93.1 % and 76.8 % had an UDVA of 20/20 or better in the A and B groups,
respectively. In the A group, 87.9 % and 96.6 % were within ±0.5 D and ±1.0 D, respectively, of the intended correction;
in the B group, 88.0 % and 97.6 % were within ±0.5 D and ±1.0 D, respectively. The efficacy index was 1.04 ± 0.19 in the
A group and 0.99 ± 0.19 in the B group. The safety index was 1.27 ± 0.17 for the A group and 1.24 ± 0.17 for the B
group. The efficacy and safety index were not significantly different between the two groups 12 months
postoperatively (p = 0.141 and p = 0.307, respectively).
Conclusions: This study showed that SMILE is effective and safe for correcting high myopia, as well as mild to
moderate myopia.
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Small incision lenticule extraction (SMILE) is a flap-free
refractive surgery, in which the corneal stromal lenticule
is cut by a femtosecond laser and removed through a
small corneal incision tunnel [1, 2]. Recently, SMILE has
been proposed as an alternative to LASIK or PRK, which
has been a popular refractive surgery technique for a
decade because the visual outcome has proved to be
generally good and the time to return to normal life after
surgery is short[3].* Correspondence: Sara514@catholic.ac.kr
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creativecommons.org/publicdomain/zero/1.0/However, complications after surgery can include dry
eyes [4], corneal haziness [5], ectasia [6], and traumatic-
ally loosened flaps [7]; SMILE is expected to remedy
these shortcomings. Studies have shown that compared
with LASIK, SMILE minimizes dry eye, while maintain-
ing higher corneal sensitivity [8, 9] and cornea tensile
strength [10, 11] after surgery. Therefore, SMILE is con-
sidered a good alternative form of refractive surgery, es-
pecially when the degree of myopic correction is large or
the cornea is thin.
There have been numerous studies [1, 2, 12–14] on
SMILE outcomes, but most reported short term results
based on6 months or less of follow up with small num-
bers of samples. Longer-term studies with larger sam-
pling sizes are necessary to establish the full capability ofle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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comes of SMILE as regards the degree of myopia. In
this study, 1-year SMILE results for mild- to moderate-
myopic patients (<−6.0 D) were compared with those
for high-myopia patients (≥ − 6.0 D) in terms of efficacy,
predictability, and safety.
Method
This retrospective study evaluated the outcome of con-
secutively treated patients with SMILE at the Onnuri
Eye Clinic in Jeonju, Korea from May 2012 to May 2014.
The analysis included all eyes with a 12-month follow-
up, spherical myopia less than −12.0 D and myopic
astigmatism less than −4.0 D cyl, a minimum age of 18
years, corrected distance visual acuity (CDVA) of 20/40
or better (>0.3 logMAR), and a minimum calculated
postoperative residual stromal bed of 250 μm. The study
included 183 eyes from 92 patients with myopia (with
and without astigmatism) who fulfilled the criteria speci-
fied above. The study was approved by the Institutional
Review Board/Ethics Committee of Yeouido St. Mary’s
Hospital, Seoul, Korea and performed in accordance
with the tenets of the Declaration of Helsinki. The
treated eyes were divided into two groups: mild- to
moderate-myopia patients (A group, <−6.0 D) and high-
myopia patients (B group, ≥ − 6.0D). The two groups
were compared with respect to the efficacy, predictabil-
ity, and safety of the surgery. The efficacy index (defined
as the `postoperative uncorrected distance visual acuity
(UDVA)/preoperative UDVA’) and the safety index
(defined as ‘postoperative CDVA/preoperative CDVA’)
were estimated.
Preoperative assessment
Patients underwent a thorough ophthalmic examination
that included autokeratometry, autorefractometry, intra-
ocular pressure tonometry (CT-80, Topcon, Japan), pupil-
lometry (Colvard, Oasis Medical, Glendora, CA), corneal
tomography, corneal thickness measurements (Galilei,
Ziemer Ophthalmic Systems, Port, Switzerland), measure-
ment of the UDVA and CDVA, measurement of manifest
and cycloplegic clinical refraction, slit-lamp evaluation,
and fundoscopy.
Surgical procedure
The same surgeon (CYT) performed all surgical proce-
dures. A VisuMax 500-kHz femtosecond laser (Carl
Zeiss Meditec AG, Jena, Germany) was used for the
SMILE treatment (frequency: 500 kHz; cut energy index:
180 nJ pulsed; spot spacing: 4.5 μm). The lenticule diam-
eter was 6.5 mm and the cap diameter was 7.5 mm. The
incision length varied from 2.0–2.5 mm, and the
intended cap thickness was 100–120 μm. The SMILE
procedure has been described previously. After surgery,all patients received a topical antibiotic for 5 days and a
topical steroid for 2 weeks. Hyaluronic acid lubricating
drops were prescribed for 2 weeks (minimum).
Postoperative evaluation
All patients were routinely examined at 1 day, 1 week, 1
month, 3 months, 6 months, and 12 months. At each
visit, CDVA, UDVA, objective and manifest refractions,
keratometry, intraocular pressure, corneal topography,
and slit-lamp examination were performed. All postopera-
tive complications were noted.
Statistical analyses
Statistical analyses were performed using the SPSS software
(ver. 18; SPSS, Chicago, IL, USA). Graphics were gener-
ated using Microsoft Excel 2007 (Microsoft Corporation,
Redmond, WA, USA). All values are given as the mean ±
standard deviation. Statistical analyses for visual acuity
were based on logMAR units. Student’s t-test was used to




Fifty-eight eyes and 125 eyes were included in the A and B
groups, respectively. The target refraction was emmetro-
pia (±0.25 D) in all eyes. The mean preoperative CDVA
was −0.069 ± 0.047 logMAR and −0.045 ± 0.052 logMAR
for the A and B groups, respectively (p = 0.02). The
mean preoperative spherical equivalent was −5.05 ± 0.71
D and −7.67 ± 1.01 D for the A and B groups, respect-
ively (p = 0.000). The central cornea thickness of the B
group (526 ± 31.5 μm) was thicker than that of the A
group (510.5 ± 29.9 μm) (p = 0.002). The expected residual
corneal bed of the A group (301.0 ± 28.0 μm) was thicker
than that of the B group (291.1 ± 26 μm) (p = 0.025). No
significant difference was evident between the two groups
with respect to age, mean corneal power, or cylinder astig-
matism (Table 1).
Efficacy
All 183 eyes were examined at 1 day, 1 week, 1 month, 3
months, 6 months, and 12 months. No significant differ-
ences were observed between groups A and B for both
postoperative uncorrected visual acuity and corrected
visual acuity (Table 2).
At 1 day, 1 week, 1 month, 3 months, 6 months, and
12 months, 65.5, 81.9, 86.8, 87.5, 89.9, and 93.1 % of eyes
in group A and 63.2, 79.2, 78.8, 80.8, 78.8, and 78.4 % of
eyes in group B, respectively, had an UDVA of 20/20 or
better. There were significant differences between two
groups in 1 month and 12 months ( P < 0.05, Pearson’s
χ2 test).
Table 1 Demographics of patients
Characteristics Group A Group B p-value
Eyes (n) 58 125
Sex (M/F) 14/44 23/102
Age (years) 30.0 ± 6.7 (18–42) 26.2 ± 5.9 (18–41) 0.094
Mean corneal power (diopter) 44.5 ± 1.6 (40.4-47) 44.10 ± 1.54 (39.4-47.6) 0.091
UDVA (log MAR) 1.59 ± 0.23 (1–2) 1.68 ± 0.22 (0.7-2) 0.034*
CDVA (log MAR) −0.069 ± 0.047(−0.1-0) −0.045 ± 0.052 (−0.1-0.1) 0.02*
IOP (mmHg) 14.69 ± 2.78 (8–20) 15.56 ± 2.46 (11–21) 0.044*
Sphere (diopter) −4.49 ± 0.77 (−5.27 - -2.25) −7.03 ± 1.15 (−10 - -4.75) 0*
Cylinder (diopter) −1.12 ± 0.78 (0 - -2.8) −1.27 ± 0.74 (0 - -3.3) 0.223
Spherical equivalence (diopter) −5.05 ± 0.71 (−3 - -6) −7.67 ± 1.01 (−11 - -6) 0*
CCT (um) 510.5 ± 29.9 (457–583) 526 ± 31.5 (462–618) 0.002*
Expected residual corneal bed (um) 301.0 ± 28.0 (253–368) 291.1 ± 26 (251–373) 0.025*
CDVA = corrected distance visual acuity; D = diopters; UDVA = uncorrected distance visual acuity D = diopters; SD = standard deviation
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A and B groups, respectively. There was no significant
difference between the two groups (p = 0.141).
Predictability and Stability
The mean postoperative spherical equivalent was −0.07
± 0.38, −0.07 ± 0.35, −0.08 ± 0.33, −0.09 ± 0.31, and −0.09
± 0.38 D in A group and −0.22 ± 0.44, −0.22 ± 0.39, −0.23
± 0.39, −0.23 ± 0.37, and −0.25 ± 0.35 D in B group at 1
week, 1 month, 3 months, 6 months, and 12 months, re-
spectively. No significant differences were evident in the
postoperative spherical equivalent between the two groups
for all follow-up visits. Additionally, there was no signifi-
cant myopic regression from 1 week to 12 months for
either group (p = 0.311 and p = 0.343, respectively; Fig. 1).
In group A, 87.9 % and 96.6 % were within ±0.5 D and
±1.0 D of the intended correction; in group B, 88.0 % and
97.6 % were within ±0.5 D and ±1.0 D, respectively.
Safety
In group A, 3.4 % of eyes lost one line of CDVA, 37 %
had an unchanged CDVA, 52.7 % gained one line, and
6.9 % of eyes gained two lines. Similarly, 3.2 % of eyes
lost one line of CDVA, 43.2 % had an unchanged CDVA,Table 2 Comparisom of uncorrected and corrected distance visual a
POD
1 day 1 week
UDVA (logMAR) Group A 0.05 ± 0.13 −0.02 ± 0.08
Group B 0.07 ± 1.3 −0.00 ± 0.09
p-value 0.301 0.367
CDVA (logMAR) Group A −0.01 ± 0.09 −0.076 ± 0.06
Group B 0.01 ± 0.09 −0.067 ± 0.06
p-value 0.146 0.317
CDVA = corrected distance visual acuity; UDVA = uncorrected distance visual acuity47.2 % gained one line, and 6.4 % of eyes gained two
lines in group B (Fig. 2). No eyes lost two lines of CDVA
in either group.
The safety index were 1.27 ± 0.17 in group A and 1.24
± 0.17 in group B. No significant difference was evident
between the two groups (p = 0.307).
Additionally, no visually threatening complications oc-
curred in either group. There were no cases of epithelial
ingrowth, severe diffuse lamellar keratitis, or keratoecta-
sia in either group.
Discussion
There is growing interest in SMILE as a new alternative
refractory surgery. Although multiple studies [1, 2, 12–14]
have investigated the surgical outcomes SMILE, most
were short-term and included only a small number of
cases. Recently, several studies [15–18] have reported
on 1-year outcomes of SMILE surgery; however, add-
itional long-term studies with larger sampling sizes are
required to determine the full potential of this method.
This is the first study to compare the 1-year SMILE out-
comes of mild- to moderate-myopia patients (Group A)
with those of high-myopia patients (Group B). Particu-
larly, it is thought that this study is a more accuratecuity of two groups
1 month 3 month 6 months 12 months
−0.05 ± 0.09 −0.08 ± 0.09 −0.09 ± 0.09 −0.09 ± 0.08
−0.02 ± 0.09 −0.04 ± 0.09 −0.04 ± 0.09 −0.04 ± 0.1
0.217 0.162 0.125 0.088
−0.12 ± 0.07 −0.13 ± 0.06 −0.15 ± 0.06 −0.18 ± 0.05
−0.08 ± 0.06 −0.09 ± 0.05 −0.10 ± 0.06 −0.14 ± 0.06
0.563 0.23 0.14 0.135
Fig. 1 Comparison of spherical equivalent refraction stability
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performed using the same energy and spot spacing laser
settings and by only one surgeon.
There was no difference in both CDVA and UDVA be-
tween the two groups through the 1-year follow-up
period. This is consistent with previous study of Hjortdal
et al. [12] which suggested that there was no relationship
between the corrected myopia amount and postoperative
efficacy in bivariate analysis.
For Groups A and B, 93.1 % and 76.8 % of eyes, re-
spectively, had 20/20 or better UDVA at 12 months. Ac-
cording to previous studies, 88 % in Sekundo et al. [15],
83 % in Xu Y et al. [17], and 96 % in Reinstein et al. [18]
had 20/20 or better UDVA at 12 months; the higher suc-
cess rate of Reinstein et al. [18] was attributed to the
relatively lower mean preoperative SE (−2.61 D), com-
pared with the others. In contrast, Group B in theFig. 2 Comparison of safety of SMILEcurrent study had a lower success rate (76.8 %), due to
its relatively high preoperative SE (−7.67 D).
In the predictability evaluation, no significant differ-
ence in the rates within ±0.5 D and ±1.0 D was evident
between Groups A and B; these results are in good
agreement with previous results [15–17] of 85–95 % for
±0.5 D and 90–100 % for ±1.0 D. Thus, SMILE surgery
seems to have a similar predictability, independent of
the amount of myopic correction.
In the safety evaluation, there was no significant differ-
ence in the safety index at 12 months; 3–4 % had one
line loss in both groups, which is comparable to the re-
sults from previous studies [15–17] indicating 1–10 % of
eyes with one line loss.
In this study, no myopic regression was observed from
1 week to 12 months in either group, which is compat-
ible with previous studies. Although Sekundo et al. [15]
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small to influence the clinical results.
In the study population, the preoperative central cor-
nea thickness and preoperative CDVA differed signifi-
cantly between the two groups, which might affect the
long-term outcomes after surgery. This is a potential
limitation of this study.
Ivarsen et al. [19] determined that the most frequent
complication of the surgery, corneal trace haze, was ob-
served in 8 % of cases. In this study, 5 % in group A and
6 % in group B exhibited grade-1 trace haze; however,
this complication did not appear to have an effect on
visual acuity. Additional complications cited in Ivarsen
et al. [19], such as epithelial ingrowth and keratitis, were
not observed in the current study.
Comparing the results at 6 and 12 months in this
study, there were no significant differences in efficacy,
predictability and safety. This is compatible with the re-
sults of previous studies that reported similar 6- [12, 14]
and 12-month visual outcomes [15–18]. These results
indicate that the visual outcome after SMILE is main-
tained for the long term.
In this study, the clinical SMILE outcome of high-
myopia patients, including efficacy, predictability, and
safety, did not differ from that of mild- to moderate-
myopia patients; however, it is noteworthy that the mean
preoperative SE was −7.70 D and the mean expected re-
sidual corneal bed thickness was 291.1 μm in the high-
myopia patients. The results of this study suggest that
SMILE surgery could be useful refractive surgery in
high-myopia patients with a relatively thin corneal
thickness.Conclusions
SMILE is effective and safe for correcting high myopia,
as well as mild to moderate myopia.
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